The Potential for Life-Changing Relief

For patients with treatment-resistant depression, traditional medications and therapies may fail to provide adequate relief, leaving them feeling hopeless and without options.

Spravato (esketamine) offers a safe and effective option for those struggling with treatment-resistant depression. Unlike traditional treatments, Spravato works rapidly—often providing relief within hours or days—helping patients regain hope and restore function in their daily lives. Its unique mechanism targets brain pathways linked to mood regulation, offering new possibilities for those who have not found success with other therapies.

Treatment

Modern Minds Health offers Spravato, an FDA-approved esketamine nasal spray administered under supervision. Combined with oral antidepressants, Spravato targets brain pathways involved in mood regulation, offering a new mechanism of action for those who have not responded to other treatments

Results

Clinical studies have demonstrated Spravato’s effectiveness:

• Rapid Symptom Reduction: Patients experienced a significant decrease in depressive symptoms within 24 hours of the first dose.

• Effective for Treatment-Resistant Depression: In clinical trials, 69% of patients showed significant improvement in depressive symptoms after four weeks of Spravato combined with an oral antidepressant.

• Sustained Efficacy: Long-term studies demonstrate that patients using Spravato, alongside oral antidepressants, had a 51% lower risk of relapse compared to those on oral antidepressants alone.

For more information, including further discussion of indication as well as potential benefits/risks, please schedule an appointment and/or feel free to review additional information prepared for patient education available here.